2024 biotech funding tracker: recent highlights …| $150 Million series A | cancer drugs | clinical in HR+ breast cancer Edgewood Oncology (United States) | $20 million series A | cancer drugs | phase 1 in… February 23, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2023 Breast cancer most studied disease area in 2022 …that breast cancer retained its position as the most-studied disease area, followed by COVID-19. Three of the top five most-studied disease areas fell within oncology, with prostate cancer the third… January 12, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Apr 2017 French Oncolytic Virus Vaccine for Breast Cancer enters Phase II After positive results in Phase I, Transgene has started Phase II with Pexa-Vec in combination with chemotherapy to treat breast cancer and sarcoma. After years of financial instability, Transgene is… April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2025 ASCO 2025: key highlights in cancer therapeutics …gastroesophageal junction cancers and shows the benefits of giving our best treatments earlier,” said Pamela Kunz, director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer… June 4, 2025 - 18 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered in the 1980s. For the prevention of cancers caused by… March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Feb 2024 Fourteen biotech companies spearheading the antibody drug conjugate industry …targeting B7-H3, a protein expressed by many different cancers including lung cancer. The ADC has shown early signs of clinical activity in solid tumors, particularly small cell lung cancer and… February 8, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Sep 2023 Recent advancements in prostate cancer research over the past year Prostate cancer is the second most commonly occurring cancer in men. More than 1.4 million people were diagnosed with prostate cancer in 2020, according to the World Cancer Research Fund… September 21, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2024 Future of cancer treatment: what will therapy look like in 2034? …New technologies related to cancer treatments: AUP-55 – A Lactic Acid Bacterial Treatment for Ovarian Cancer, Bladder Cancer, and Peritoneal Carcinomatosis – Aurealis Therapeutics Small RNA Therapeutics for Prostate Cancer… February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Sep 2023 Five recent advancements in ovarian cancer research over the past year …for a Range of Cancer Types Including Triple Negative Breast Cancer – Institute of Cancer Research (ICR) Vaccine Therapy for Treatment of Endometrial and Ovarian Cancer – Henry Jackson Foundation… September 5, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2022 Positive results from study of drug to treat patients with breast cancer published Results from a phase 1b study of a drug to treat patients with androgen receptor positive (AR+) metastatic breast cancer (mBC) in China were published yesterday (September 28). Kintor Pharmaceutical… September 29, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2024 2024: a year of breakthroughs for endometrial cancer? …with specific molecular alterations who have advanced or recurrent endometrial cancer,” said Cohen. Technologies related to endometrial cancer Vaccine Therapy for Treatment of Endometrial and Ovarian Cancer – Henry Jackson… September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? …traditional methods. It showed success in cancers such as lung, colorectal, and breast cancer. Additionally, Johns Hopkins researchers have developed the DELFI-Pro liquid biopsy test, which combines AI with cell-free… October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email